Pegylated Interferon Alfa-2a Monotherapy for Hemodialysis Patients with Acute Hepatitis C
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Pegylated Interferon Alfa-2a Monotherapy for Hemodialysis Patients with Acute Hepatitis C

Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Lin, Jou-Wei;Chen, Shih-I;Hung, Peir-Haur;Tsai, Hung-Bin;Lai, Ming-Yang;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng;
clinical infectious diseases 2010 Vol. 51 pp. 541-549
116
chen-hua2010clinicalpegylated

Abstract

Abstract. Background. Hemodialysis patients are at risk of hepatitis C virus (HCV) infection. However, little is known about the efficacy and safety of pegylate

Keywords

Access

URL:
https://doi.org/10.1086/655682

Citation

ID: 271150
Ref Key: chen-hua2010clinicalpegylated
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
271150
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store